Posts

Nov 13, 2019 12:45am
From Maureen Tacke, Program Manager, Lab, Hematology/Coagulation, St. Luke's Health System: Our institution is working towards a conversion to Anti-Xa monitoring for patients on UFH , however, our pharmacy group has a question. What are other facilities doing if a patient presents, needs UFH , and is already on a DOAC (the baseline anti-Xa or PTT is elevated)?
1 Comment
Oct 29, 2019 12:04pm
Our November, 2019 Quick Question asks, "What may you substitute for the PT when LAC prolongs the PT
1 Comment
Oct 29, 2019 11:49am
Here are the results to our October, 2019 Quick Question, "What factor assays do you perform to distinguish liver disease from vitamin K deficiency?"
0 Comments
Oct 28, 2019 2:06pm
From Heather DeVries, Indiana University: I’ll make this one short and sweet…how many samples should be used in a cumulative summation study?
0 Comments